DSDaniel M. Spielman

Daniel M. Spielman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daniel M. Spielman has a total of 65 co-authors. Here are the top co-authors by number of shared publications:

  • Meng Gu

    Department of Radiology Stanford University School of Medicine Stanford California USA

    6 shared publications
  • Kenichi Okamura

    Department of Cardiothoracic Surgery Stanford University School of Medicine Stanford California USA

    4 shared publications
  • Adolf Pfefferbaum

    Neuroscience Program SRI International Menlo Park CA USA

    3 shared publications
  • Frank L. Hanley

    Department of Cardiothoracic Surgery Stanford University School of Medicine Stanford California USA

    3 shared publications
  • Masafumi Shibata

    Department of Cardiothoracic Surgery Stanford University School of Medicine Stanford California USA

    3 shared publications
  • Ralph Hurd

    Department of Radiology Stanford University School of Medicine Stanford California USA

    3 shared publications

Latest Publications

  • Open Access

    Cerebellar Crus I and Crus II Structure and Excitation/Inhibition Balance in Autism Spectrum Disorder

    by John P. Hegarty, Hamidreza Komaki, Meng Gu, Kurtis Young, Nneoma Ogbonnaya, Daniel M. Spielman, Antonio Y. Hardan

  • Open Access

    Preclinical 1 H MRS Study of a Porcine Model Shows Evidence and Mechanisms for Acute Neuronal Injury in Neonatal Cardiopulmonary Bypass ( CPB ) Surgery

    by Aaron Omon, Meng Gu, Ralph Hurd, Kirk Riemer, Frank Hanley, Daniel Spielman

    Purpose: Congenital heart disease affects 1% of US births, with some infants requiring cardiothoracic surgery under cardiopulmonary bypass (CPB). Optimal surgical parameters to minimize neuronal injury are unknown. We used serial 1 H MRS in a neonatal CPB porcine model to assess acute neuronal damage and associated injury mechanisms. Methods: 2‐week‐old piglets ( N = 26) were placed in a 3 T MRI to study brain metabolism during CPB. Dynamic single‐voxel 1 H MRS brain data were acquired while animals underwent CPB via antegrade cerebral perfusion (ACP) or complete circulatory arrest (CA) with findings quantified via ratios to the average total creatine (tCr ave ). Hypothermic temperatures ranged between 18°C–37°C, and blood glucose (Glc) levels immediately prior to CA ranged from 54 to 700 mg/dL. Acute neuronal injury at ∼1 h post‐CA was assessed by decreased N‐acetyl aspartate (NAA) and correlated with three potential injury mechanisms: (1) energy failure via pre‐CA Glc and phosphocreatine (PCr) loss during CA, (2) reperfusion injury via elevated succinate (Suc) at end of CA, and (3) ammonia toxicity via post‐CA glutamine/glutamate (Gln/Glu) levels. Results: A temperature‐dependent NAA/tCr ave decrease was observed for the CA studies, whereas no decreases were seen in the ACP animals. Multiple linear regression analysis revealed that NAA/tCr ave loss was significantly associated with pre‐CA brain Glc/tCr ( p = 0.001) and average PCr/tCr ave levels during CA ( p = 0.024). NAA/tCr ave losses were not significantly associated with Suc/tCr ave or Gln/Glu changes. Conclusions: 1 H‐MRS in a CPB model identified neuronal injury ∼1 h post CA, with injury severity correlating with pre‐CA Glc/tCr ave levels and loss of PCr/tCr ave during CA.

  • Open Access

    Differentiating Creatine and Phosphocreatine In Vivo Using 3 T 1 H MR Spectroscopy

    by Ralph E. Hurd, Meng Gu, Philip M. Adamson, Kenichi Okamura, Masafumi Shibata, Yoshikazu Ono, Moussa Haidar, Kirk Riemer, Frank L. Hanley, Daniel M. Spielman

    Purpose: Validation and improvements to the proton MR spectroscopic measurement of creatine and phosphocreatine in vivo at 3 T. Methods: Spectral simulations were used to evaluate and explore the mitigation of LCModel fitting bias due to lineshape, signal‐to‐noise (SNR) and non‐metabolite backgrounds with a focus on phosphocreatine and the spline regularization settings in the fitting model. Results: Although phosphocreatine and creatine are visually unresolved, excellent fitting estimates are achieved in the absence of non‐metabolite background using default settings. However, in the presence of non‐metabolite background, bias is observed and depends on lineshape, SNR and differences in the non‐metabolite background. A more flexible setting for the LCModel spline largely mitigates this bias, allowing for the confidence to use proton MRS for PCr dynamic studies. Conclusion: Without prior knowledge of the non‐metabolite signal, default settings of LCModel can introduce significant bias. Modified setup for LCModel improves quantitation of phosphocreatine and reduces bias in the overall set of metabolites.


  • The circulatory arrest recovery ammonia problem (CARAP) hypothesis: A proton magnetic resonance spectroscopy (1H-MRS) study of brain metabolism during neonatal cardiopulmonary bypass surgery

    by Daniel Spielman, Meng Gu, Hunter Liu, Shie-Chau Liu, Ralph Hurd, Kirk Riemer, Kenichi Okamura, Masafumi Shibata, Paul Shuttleworth, Zachary Kleiman, et al.


  • Detection of elevated succinate in brain during circulatory arrest in a piglet model: A 3T 1H MR spectroscopy study

    by Ralph E. Hurd, Meng Gu, Kenichi Okamura, Masafumi Shibata, Yoshikazu Ono, Moussa Haidar, R. Kirk Riemer, Frank L. Hanley, Daniel M. Spielman

    Purpose: To measure and validate elevated succinate in brain during circulatory arrest in a piglet model of cardiopulmonary bypass.Methods: Using data from an archive of 3T 1H MR spectra acquired in previous in‐magnet studies, dynamic plots of succinate, spectral simulations and difference spectra were generated for analysis and validation.Results: Elevation of succinate during circulatory arrest was observed and validated. Fitting bias was evaluated as a function of the line‐widths and signal‐to‐noise ratios of the archived data. Succinate increases were independent of bypass temperature. Succinate elevation was also not observed with antegrade cerebral perfusion.Conclusion: Although spectrally overlapped and at sub‐millimolar levels, elevated brain succinate can be reliably measured by dynamic MR spectroscopy at 3T. Noise dependent bias of the stronger overlapping signals did not impact the succinate measurement. Elevated succinate during circulatory arrest and its recovery after reperfusion was observed. This finding is consistent with earlier reports that correlate elevated succinate with ischemic‐reperfusion injury.


  • Deuterium metabolic imaging for 3D mapping of glucose metabolism in humans with central nervous system lesions at 3T

    by Philip M. Adamson, Keshav Datta, Ron Watkins, Lawrence D. Recht, Ralph E. Hurd, Daniel M. Spielman

    Purpose: To explore the potential of 3T deuterium metabolic imaging (DMI) using a birdcage 2H radiofrequency (RF) coil in both healthy volunteers and patients with central nervous system (CNS) lesions.Methods: A modified gradient filter, home‐built 2H volume RF coil, and spherical k‐space sampling were employed in a three‐dimensional chemical shift imaging acquisition to obtain high‐quality whole‐brain metabolic images of 2H‐labeled water and glucose metabolic products. These images were acquired in a healthy volunteer and three subjects with CNS lesions of varying pathologies. Hardware and pulse sequence experiments were also conducted to improve the signal‐to‐noise ratio of DMI at 3T.Results: The ability to quantify local glucose metabolism in correspondence to anatomical landmarks across patients with varying CNS lesions is demonstrated, and increased lactate is observed in one patient with the most active disease.Conclusion: DMI offers the potential to examine metabolic activity in human subjects with CNS lesions with DMI at 3T, promising for the potential of the future clinical translation of this metabolic imaging technique.


  • Proton magnetic resonance spectroscopy assessment of neonatal brain metabolism during cardiopulmonary bypass surgery

    by Daniel M. Spielman, Meng Gu, Ralph E. Hurd, R. Kirk Riemer, Kenichi Okamura, Frank L. Hanley

    Here, we report on the development and performance of a robust 3‐T single‐voxel proton magnetic resonance spectroscopy (1H MRS) experimental protocol and data analysis pipeline for quantifying brain metabolism during cardiopulmonary bypass (CPB) surgery in a neonatal porcine model, with the overall goal of elucidating primary mechanisms of brain injury associated with these procedures. The specific aims were to assess which metabolic processes can be reliably interrogated by 1H MRS on a 3‐T clinical scanner and to provide an initial assessment of brain metabolism during deep hypothermia cardiac arrest (DHCA) surgery and recovery. Fourteen neonatal pigs underwent CPB surgery while placed in a 3‐T MRI scanner for 18, 28, and 37°C DHCA studies under hyperglycemic, euglycemic, and hypoglycemic conditions. Total imaging times, including baseline measurements, circulatory arrest (CA), and recovery averaged 3 h/animal, during which 30–40 single‐voxel 1H MRS spectra (sLASER pulse sequence, TR/TE = 2000/30 ms, 64 or 128 averages) were acquired from a 2.2‐cc right midbrain voxel. 1H MRS at 3 T was able to reliably quantify (1) anaerobic metabolism via depletion of brain glucose and the associated build‐up of lactate during CA, (2) phosphocreatine (PCr) to creatine (Cr) conversion during CA and subsequent recovery upon reperfusion, (3) a robust increase in the glutamine‐to‐glutamate (Gln/Glu) ratio during the post‐CA recovery period, and (4) a broadening of the water peak during CA. In vivo 1H MRS at 3 T can reliably quantify subtle metabolic brain changes previously deemed challenging to interrogate, including brain glucose concentrations even under hypoglycemic conditions, ATP usage via the conversion of PCr to Cr, and differential changes in Glu and Gln. Observed metabolic changes during CPB surgery of a neonatal porcine model provide new insights into possible mechanisms for prevention of neuronal injury.


  • Real-Time in Vivo Detection of H2O2 Using Hyperpolarized 13C-Thiourea

    by Arif Wibowo, Jae Mo Park, Shie-Chau Liu, Chaitan Khosla, Daniel M. Spielman

    Reactive oxygen species (ROS) are essential cellular metabolites widely implicated in many diseases including cancer, inflammation, and cardiovascular and neurodegenerative disorders. Yet, ROS signaling remains poorly understood, and their measurements are a challenge due to high reactivity and instability. Here, we report the development of 13C-thiourea as a probe to detect and measure H2O2 dynamics with high sensitivity and spatiotemporal resolution using hyperpolarized 13C magnetic resonance spectroscopic imaging. In particular, we show 13C-thiourea to be highly polarizable and to possess a long spin–lattice relaxation time (T1), which enables real-time monitoring of ROS-mediated transformation. We also demonstrate that 13C-thiourea reacts readily with H2O2 to give chemically distinguishable products in vitro and validate their detection in vivo in a mouse liver. This study suggests that 13C-thiourea is a promising agent for noninvasive detection of H2O2 in vivo. More broadly, our findings outline a viable clinical application for H2O2 detection in patients with a range of diseases.


  • Hyperpolarized Sodium [1-13C]-Glycerate as a Probe for Assessing Glycolysis In Vivo

    by Jae Mo Park, Marvin Wu, Keshav Datta, Shie-Chau Liu, Andrew Castillo, Heather Lough, Daniel M. Spielman, Kelvin L. Billingsley

    Hyperpolarized 13C magnetic resonance spectroscopy (MRS) provides unprecedented opportunities to obtain clinical diagnostic information through in vivo monitoring of metabolic pathways. The continuing advancement of this field relies on the identification of molecular probes that can effectively interrogate pathways critical to disease. In this report, we describe the synthesis, development, and in vivo application of sodium [1-13C]-glycerate ([13C]-Glyc) as a novel probe for evaluating glycolysis using hyperpolarized 13C MRS. This agent was prepared by a concise synthetic route and formulated for dynamic nuclear polarization. [13C]-Glyc displayed a high level of polarization and long spin–lattice relaxation time—both of which are necessary for future clinical investigations. In vivo spectroscopic studies with hyperpolarized [13C]-Glyc in rat liver furnished metabolic products, [13C]-labeled pyruvate and lactate, originating from glycolysis. The levels of production and relative intensities of these metabolites were directly correlated with the induced glycolytic state (fasted versus fed groups). This work establishes hyperpolarized [13C]-Glyc as a novel agent for clinically relevant 13C MRS studies of energy metabolism and further provides opportunities for evaluating intracellular redox states in biochemical investigations.